Skip to main content


Featured Article
“Unfortunately, we did not achieve a statistically significant reduction in the Positive and Negative Syndrome Scale (PANSS) total score in this study,” said Acadia Pharmaceuticals president Serge…
Most oral antipsychotics are effective for acute treatment of multi-episode schizophrenia in adults, but it's not clear which, if any, is best, according to a new network meta-analysis comparing 32…


Mark Munger, PharmD, explains why careful observation of patients being treated with ACEi based on salt classification may be warranted in patients with active symptoms or with a family history of schizophrenia.
Formulary decisions for treating schizophrenia must balance saving costs and improving medication  adherence without contributing to the disease burden.
Managing Mental Health is a 3-part series dedicated to exploring the challenges managed care professionals face regarding the treatment of mental health illnesses, with a specific focus on dementia, schizophrenia, and depression.
Long-acting injectable (LAI) antipsychotics are highly effective in the management of schizophrenia and associated with a number of potential advantages over oral antipsychotics. First-generation LAIs (LA1s) have been available for more than 50…
Back to Top